Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines
Authors
Hao Cai (ORCID: https://orcid.org/0000-0002-1492-4701)
Kui Luo (ORCID: https://orcid.org/0000-0002-3536-1485)
Qiyong Gong (ORCID: https://orcid.org/0000-0002-5912-4871)
Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines
Hao Cai, Kui Luo, Qiyong Gong, Yuxin Zhang et al.
Citations
7 citations
Journal
EBioMedicine
Topics
Nanoplatforms for cancer theranostics
Field-Weighted Citation Impact (FWCI)
4.72
article
Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines
Hao Cai, Kui Luo, Qiyong Gong, Yuxin Zhang, Jing Jing, Siying Li, Xinying Cheng, Xue Li, Yi Lü, Yunkun Li, Na Hu
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
EBioMedicineVol. 123
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), West China Hospital of Sichuan University (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines — Hao Cai, Kui Luo, et al. · EBioMedicine (2025) | TGRS Research Map | TGRS